Anoo Bhuyan covers health policy for The Wire. Before this she worked at Outlook Magazine, National Public Radio and BBC. She did her postgraduate degree in Conflict and Development Studies from SOAS, University of London. She tweets at @AnooBhu and archives her work at www.anoobhuyan.wordpress.com
This follows The Wire’s exclusive story this week about Derek Yach targeting health leaders with grant money from his foundation, which is funded by the tobacco industry.
Leaked emails reveal that the foundation is actively making offers of grants to officials at the WHO as well as people in India and abroad without explicitly revealing its single source of funding – Philip Morris International.
Taking charge as WHO’s deputy director general in December, India’s Dr Soumya Swaminathan speaks to The Wire about global health, where India stands on medical research and how women can get ahead in the workplace.
Gurugram’s Fortis Hospital has denied allegations of medical negligence and overcharging.
Report looks at 26 years of health data in India to see trends in diseases and risks in every state. The conclusion is that large health inequalities exist among states.
The report, The Lancet’s second one this month, covers five themes where health and climate change overlap – heatwaves, air pollution, labour capacity, food security and infectious diseases.
Healthcare watchers are calling on India to resist the free trade agreement’s provisions which could compromise India’s ability to keep supplying cheaper generic drugs to the world.
The university appears to be representing pharmaceutical companies Pfizer, Medivation and Astellas in its patent battle. They aren’t telling the Delhi high court this, but they do talk about it in other documents.
The government’s re-launched universal immunisation programme had a target of achieving full immunisation by 2020. It has now decided to advance it to 2018.
Amid safety concerns in the US, EU, Australia and India, the company has globally withdrawn two of its stents which it had marketed as innovative.
This comes after Maneka Gandhi recently said the government was considering moving from food transfers to cash transfers.
The government is finalising a pilot project in line with NITI Aayog’s recent suggestion that children and mothers be given cash transfers instead of cooked or uncooked food.
Former attorney general Mukul Rohatgi talks about the recent right to privacy judgment, his objections to it, paranoia surrounding the Aadhaar and more.
“I did not mean that, that privacy is nothing. I only placed the position of the Supreme Court judgements.”
The Intelligence Bureau has been investigating the funding of NGOs working to reduce tobacco usage. It is unusual for health sector organisations to be investigated by the highest agencies.
Pneumonia kills two lakh children in India every year, but the vaccine has so far been available only in the private market at a high price.
The Swadeshi Jagran Manch has accused the pharmaceutical department of undermining the National Pharmaceutical Pricing Agency and diluting its powers.
The policy proposes a reversal to “monitoring” the prices of drugs, instead of “controlling” them, although the Supreme Court had earlier ruled against this.
“One can keep blaming us for things but this is an exercise which has been neglected for the last 20 years in the state of UP, Bihar, Assam,” UP health minister Siddharth Nath Singh said.
With the government giving 23 natural reasons for the children’s deaths, the official line eliminates any human or institutional hand or negligence.
The UP government insists that the deaths are unrelated to any oxygen shortage, though they are yet to explain why 23 children died on August 10.
A committee working under the ministry has written to a Nobel laureate, academics and governments countering their criticisms of homeopathy.
The Centre’s pharmaceutical pricing agency has issued a demand-notice for Rs 1,26,547 from a Haryana hospital, which sources say is the first of many more recoveries.
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIP-plus scenario.
Worried about the impact of the trade negotiations, a consortium of civil groups called the People’s Resistance Forum has asked for the talks to be called off.
The Tamil Nadu government conducted three tests in different states before confirming the positive case of Zika virus.
Of the 134 cases that India reported, the cause of death among 96% of children was listed as being “unclassifiable” or “coincidental due to something other than vaccine.”
In their letter, many individuals and organisations stated that a country with as much poverty as India should not enforce patents on drugs and vaccines the same way industrialised countries have.
The public interest litigation seeks the divestment of 32% shares held by public sector insurance companies in the tobacco major ITC.
Until the new notification making Aadhaar compulsory under the government’s Revised National Tuberculosis Control Programme, healthcare workers say did not even know cash benefits were available.
In 2012, the BJP’s presidential nominee testified in support of former BJP president Bangaru Laxman, who was eventually convicted of corruption.
Even as the Indian Medical Association head claims he was unaware of the polarising VHP leader’s past, others say he could help doctors gain attention to their demands.
India was moved up from the safest category 4 to category 2 in WHO’s country-classification table for the Zika virus.
Indian officials say there was no responsibility to inform the WHO about the three Zika cases, while the WHO says this is not true.
While the Integrated Disease Surveillance Programme reports in detail about food poisoning, cholera and even Crimean-Congo hemorrhagic fever, it has reported zero cases of Zika, though the government and WHO confirmed three cases.
In November 2016, the Delhi high court had ordered the government to finalise a policy on rare disease as patients repeatedly petitioned the court asking that the expensive drugs required for treatment be provided for free.
NITI Aayog’s research on drug deregulation continues unabated, even as two Union ministers have said they will follow the prime minister’s vision on affordable healthcare.
The government’s premier policy-formulating agency recently recommended measures to deregulate the pharmaceutical sector and make essential medicines more expensive.
Swadeshi Jagran Manch has accused several government arms of lobbying for pharmaceutical companies and negating the NPPA’s attempts to make medicines affordable.
India’s drug controller is allowing Abbott’s coronary stent, Absorb BVS, to start fresh clinical trials, though it has been red-flagged by the US and Australia.